z-logo
open-access-imgOpen Access
Diabetes is not associated with an increased risk of hepatocellular carcinoma in patients with alcoholic or hepatitis C virus cirrhosis
Author(s) -
Carlos Rodríguez-Escaja,
C.A. Navascués,
Luisa GonzálezDiéguez,
Valle Cadahía,
Marı́a Varela,
Miguel A. Jorge,
Andrés Castaño-García,
Manuel Rodrı́guez
Publication year - 2020
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2020.6953/2020
Subject(s) - medicine , hepatocellular carcinoma , cirrhosis , diabetes mellitus , gastroenterology , hepatitis c virus , alcoholic liver disease , alcoholic hepatitis , virus , virology , endocrinology
diabetes has been reported as a risk factor for hepatocellular carcinoma (HCC) in population-based studies but there are controversial data in patients with cirrhosis. Metformin could have a protective role in HCC development. The aim of this study was to determine the influence of diabetes on the risk of developing HCC in patients with alcohol- and hepatitis C virus (HCV)-related cirrhosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here